Objectives: Cardiac remodeling secondary to myocardial infarction is associated with hypertrophy of surviving myocardium and altered cardiac gene expression. The present study examined the spatiotemporal expression of cardiac contractile protein and peptide Ž . hormone mRNA following left ventricular myocardial infarction LVMI in the rat heart. Methods: LVMI was produced in Wistar rats by Ž . Ž . ligation of the left anterior descending coronary artery and mRNA levels of cardiac a-actin cACT , skeletal a-actin sACT , ventricular Ž . Ž . Ž . myosin light chain-2 MLC-2v , b-myosin heavy chain b-MHC and pre-proatrial natriuretic peptide ppANP were examined at 24 h, 1 .
Introduction
Alterations in mRNA levels of actin and myosin isoforms have been described in a variety of in vitro and in ) Corresponding author. Tel: q61 3 9496 3420; Fax: q61 3 9459 3510; E-mail: richardy@ariel.ucs.unimelb.edu.au vivo models of cardiac myocyte hypertrophy. Phenotypic Ž . conversion from the constitutive cardiac a-actin cACT and ventricular a-myosin heavy chain forms of mRNA in Ž . the rat to the inducible skeletal a-actin sACT and b-Ž . myosin heavy chain b-MHC forms has been reported Time for primary review 18 days.
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( )following stimulation of cultured neonatal rat cardiocytes w x w x 1 , subsequent to aortic stenosis 2-5 , and following w x aortocaval fistula 6 , chronic coronary artery constriction w x Ž . 7 and left ventricular myocardial infarction LVMI in w x the rat 8 . Switching between myosin heavy chain protein forms has the potential to alter the contractile properties of the recombinant cardiac muscle fiber due to slower adeno-Ž . sine triphosphate ATP cycling of the induced b-MHC protein, producing a slower, more energy-efficient contracw x tion 9 . Recent evidence that over-expression of sACT mRNA in BALBrc mice correlated with increased myw x ocardial contractility 10 , confirms the potential for transcriptional control of contraction in hypertrophic myocardium.
Increased mRNA expression and cellular accumulation Ž . of constitutive ventricular myosin light chain-2 MLC-2v and re-expression of ventricular pre-proatrial natriuretic Ž . peptide mRNA ppANP are also reported as features of w x the hypertrophic process 11-13 . Myosin LC-2v protein has been shown to regulate heavy chain myosin ATPase in w x vitro 14 , and its phosphorylation is known to affect the Ca 2q -sensitivity of atrial and ventricular muscle fibers w x 15 . Re-expression of ventricular ppANP mRNA may serve to attenuate increased pre-and after-load, secondary w x to cardiac dysfunction 16 .
Thus far, however, no studies have used in situ hybridization histochemistry to examine the spatiotemporal distribution of these cardiac mRNAs following LVMI. An advantage of this technique compared to Northern blot analysis, is the ability to determine, in serial sections, the regional localization of mRNA in atrial, left and right ventricular and interventricular septal chambers. We have therefore employed in situ hybridization histochemistry using specific 35 S-labeled oligonucleotide probes to examine the distribution of several cardiac mRNA species 24 h, 1 and 4 weeks after LVMI-induced cardiac overload. The oligonucleotide probes chosen represent both constitutive Ž . Ž 'adult'; cACT, MLC-2 and inducible 'fetal'; sACT, . b-MHC molecular markers of the cardiac contractile phenotype, as well as ppANP, a known marker of ventricular w x hypertrophy 16 .
A preliminary account of this work was reported to the 15th Scientific Meeting of the International Society of w x Hypertension, Melbourne, Australia 17 .
Methods

Animals
Wistar rats were obtained from the Biological Research Laboratories, Austin and Repatriation Medical Centre Ž . Heidelberg, VIC, Australia . All studies were performed in agreement with, and according to, 
Left Õentricular myocardial infarction
Female Wistar rats with a mean weight of 189 " 3 g were subjected to left anterior descending coronary artery Ž . LAD ligation to produce LVMI, as described by Pfeffer w x et al. 18 , with slight modifications. Rats were rapidly anesthetized with ether, orally intubated and artificially Ž ventilated with 2% halothane in oxygen Fluothane, ICI . Pharmaceuticals, Melbourne, VIC, Australia . A left thoracotomy was performed within the fourth intercostal space, the pericardium gently ruptured and the heart exteriorized. A 1-mm long polypropylene suture was placed between the pulmonary outflow tract and the left atrium, permanently ligating the LAD 2-3 mm from its origin. The heart was then returned to the thoracic cavity, the overlying pectoral muscles sutured with a purse-string, plain gut suture and the lungs hyper-inflated with positive end-expiratory pressure. The skin was then closed with a continuous silk suture and the animals allowed to recover. Shamoperated animals were treated similarly, except that the ligature around the coronary artery was not tied.
Upon recovery, rats were assigned to one of three groups -24 h, 1 week and 4 weeks post-LVMI -and had access to standard rat chow and tap water ad libitum. Body weight was measured pre-LVMI, 24 h post-LVMI and thereafter at weekly intervals.
Rats were killed by cervical dislocation and decapitation and the heart was rapidly removed, placed in ice-cold isotonic saline, gently palpated to remove excess blood and dissected free of associated adipose and connective tissue. The left ventricle was flushed via the aorta and the heart blotted dry and weighed. Similarly, the lungs, liver and right kidney were removed, dissected free of associated adipose and connective tissue and weighed. The heart was then filled via the aorta with Tissue-tek OTC mounting Ž . media Miles Laboratories, Elkhart, IN, USA and quickly Ž . frozen over liquid N -1 min . Frozen hearts were stored 2 Ž . -2 weeks at y708C until further processed.
In the study groups, LVMI was confirmed macroscopically and cardiac hypertrophy by changes in heart and lung weights expressed either as g wet weight, or as a propor-Ž . tion of body weight Table 1 . In previous studies conw x ducted in our laboratory 19 , rats possessing infarcts occupying G 40% of the left ventricular endocardial circumference could be identified from their heart-and lungrbody weight ratio changes. For this reason, only rats with evidence of LVMI and increased heart-and lungrbody weight ratio G 29% and G 59%, respectively, were selected for evaluation of cardiac mRNA levels. 
Tissue preparation
Ž . Serial coronal sections 14 mm of heart tissue were cut on a cryostat at y188C with the cutting plane oriented parallel to the left-right atria axis. Heart sections containing complete atrial and ventricular chamber profiles were thaw-mounted onto poly-L-lysine-coated slides, air-dried Ž . and stored at y208C -2 days . Slides were then washed Ž in 1 = SSC 1 = SSC: 0.15 M NaCl, 15 mM Na citrate, pH . 7.0 to remove extraneous blood and mounting compound Ž . and dehydrated in serial ethanol washes 70%, 95%, 100% Ž . prior to storage in 100% ethanol at 48C -2 weeks .
Infarct size determination
Ž
. In an additional experiment n s 6 rats , representative transverse infarct size was determined at 1 week post-Ž LVMI. Four to five fresh-frozen, transverse sections 5 . mm were cut parallel to the atrioventricular groove, with sections taken at 1-1.2-mm intervals from the apex. Sections were stained with either hematoxylin and eosin, or Masson's trichrome and subjected to computer-assisted Ž planimetry MCID, Imaging Research, St. Catharines, On-. tario, Canada , according to the method of Pfeffer and w x co-workers 18 . Briefly, the epi-and endocardial circumferences of the left ventricle and scar were measured for each digitized section image, summed separately for each animal, and expressed as a ratio of scar length-to-left ventricular circumference for each surface. These two ratios were averaged and expressed as a percentage, representative of the combined left ventricular epi-and endocar-Ž . dial surface area occupied by the infarct scar infarct size . w x a specific activity of 1.0-2.5 = 10 dpmrmg 28 . Probes Ž . 2 pgrml, 60-70 ml per slide were hybridized to heart sections overnight at 428C in a buffer containing 50% formamider10% dextran sulfater4= SSC and 200 mM dithiothreitol. 'Non-specific hybridization' was measured in the presence of a 100-fold excess of unlabeled probe. Ž Slides were washed in 1 = SSC containing 20 mM b-. mercaptoethanol for 60 min at 558C, rinsed in room temperature 1 = SSC, 0.1 = SSC, serially dehydrated in ethanol and air dried. Sections were then exposed to X-ray Ž film Kodak XAR-5, Ajax Chemicals, Melbourne, VIC, . Australia for 1-20 days depending on hybridization signal strength, prior to development.
Myocyte morphometry
Quantification of cardiac mRNAs
Cardiac mRNA levels were quantified using computer-Ž . assisted, densitometric image analysis MCID . Relative Ž . optical densities ROD of autoradiographic images were converted to dpmrcm 2 by interpolation from standard curves generated on individual films, from labeled brain w x paste standards co-exposed with the tissue sections 26 . As hybridization signal strength differed for each probe, films were exposed for different lengths of time with a single set of standards designed to encompass and exceed the dynamic range of the X-ray film over a wide range of 2 Ž
2
. dpmrcm values eg. 3-30 000 dpmrcm for sACT . These standards were used to define the linear portion of the standard curve for each individual film after adjusting for 35 S-decay. Duplicate film exposures of sections and standards were only required for ppANP mRNA, where Ž . Ž . 1-day atria and 3-day ventricles exposures were performed due to significant differences in hybridization sig-Ž . nal strength high in atria, lower in ventricles . Total w 35 x hybridization signal of a-S dATP-labeled probes was determined by manually outlining discrete cardiac chambers and averaging total hybridization signal measured in three consecutive serial sections from each animal. Total hybridization values less than the mean q 2 s.d. of the 'non-specific hybridization' level measured on two consec-Ž . utive serial sections were defined as undetectable UD .
Statistical analysis
All data are given as mean " s.e.m. Differences between groups were evaluated by 2-way analysis of vari-Ž ance ANOVA; CLR-ANOVA, Clear Lake Research, Clear . Ž . Ž Lake, TX, USA with surgery sham, LVMI and time 24 . h, 1 week, 4 weeks as the main effects. Body and organ weights were further analyzed by simple effects testing to determine interaction terms with an interaction considered significant at the P -0.05 level. Differences in myocyte width were evaluated by 1-way ANOVA, with surgery and time main effects, followed by Tukey-Kramer multiple comparisons tests. Total hybridization signal differences were analyzed by two-way ANOVA with the error mean square from the ANOVA used to calculate 95% confidence intervals of the ratio of LVMIrnaive levels. An interval range that did not include a 100% value was considered significant at the P -0.05 level.
Results
Assessment of LVMI
Infarct size and myocyte morphometry
Infarct size in a representative group of rats with increased heart-and lungrbody weight ratio G 29% and G 59%, respectively at 1 week post-LVMI, was 44. 
Heart, lung weight changes
In situ hybridization studies were performed in groups of 5 rats at 24 h, 1 week and 4 weeks post-LVMI and in groups of 3-6 sham-operated rats at each time point. Macroscopic evidence of left ventricular free-wall infarc-Ž . tion wall thinning, fibrous plaque was present in all ligated hearts, with no evidence of infarction in sham-operated hearts. Heartrbody wet weight ratios were signifi-Ž . cantly elevated at 24 h 1.3-fold , largely as a result of the Ž characteristic acute inflammation interstitial edema, infil-. tration and ischemic cardiomyocyte swelling seen at this w x early time 29 . At 1 and 4 weeks post-LVMI, heartrbody wet weight increased 1.3-1.8-fold relative to sham controls, reflecting the development of concentric and eccentric hypertrophy of overloaded myocardium. Similarly, lungrbody wet weight ratios were increased from 24 h Ž . post-LVMI 1.6-fold relative to sham controls and in-Ž . creased further over 1 and 4 weeks 1.9-2.9-fold , due to the characteristic pulmonary edema secondary to left venw x Ž . tricular dysfunction 29 Table 1 . Body weight was unal-Ž . tered as a result of LVMI Table 1 and liver and kidney Ž . weights were similarly unaffected data not shown . 
Atrial natriuretic peptide mRNA
Sham leÕels
Atrial ppANP mRNA levels were, on average, 14.6-fold higher than ventricular levels, which were low, but de-Ž . tectable Table 2 . Localized ppANP mRNA expression appeared transiently induced by sham-surgery in the left ventricular free-wall at 24 h, but returned to basal levels by Ž . 1 week Fig. 2A,C . 
LVMI leÕels
Twenty-four hours post-LVMI, left, but not right, atrial ppANP mRNA levels, measured as dpmrcm 2 , were signif-Ž icantly reduced 55% reduction; P -0.05; Table 2, Fig. . 2B . In the left ventricular free-wall, ppANP mRNA expression was restricted to the endocardial surface surrounding the infarcted area, with no mRNA detectable in the remaining free-wall. In contrast, infundibular, interventricular septal and right ventricular ppANP mRNA levels were Ž . markedly induced at 24 h 2.7-, 2.1-fold; P -0.05 , with the highest levels expressed in the septal endocardium, at Ž . the apex and in regions of the right ventricle Fig. 2B . At 1 week post-LVMI, atrial ppANP mRNA levels were indistinguishable from sham levels, while left ventricular Ž . levels were further increased 3.8-fold; P -0.05; Table 2 , particularly in the epicardium bordering the infarct area Ž . and in the infundibulum and papillary muscle Fig. 2D . High ppANP mRNA levels were evident at the apex of the Ž . heart and in the septum 2.5-fold increase; P -0.05 where there was a gradient of expression that was maximal at the left ventricular endocardial surface. Expression of ppANP mRNA was still evident in discrete regions of the right ventricle at 1 week. By 4 weeks, considerable remodeling of the ventricles had occurred with the infarcted area of the left ventricular free-wall now thinned, dilated and fibrotic, with few remaining myocytes. At this time, atrial Table 1 . % 95% CI , LVMI levels as a % of sham-operated rats with 95% Ž . ) confidence interval ANOVA . P -0.05, significantly different to sham-operated rats at respective time points. 'Limit of detection' was defined as meanq2 s.d. of 'non-specific' hybridization levels; for ppANP mRNA this was 64 dpmrcm 2 . ppANP mRNA levels were at sham levels, while the infundibulum, papillary muscle and endocardium border-Ž . ing the infarcted area accounted for a 3.3-fold P -0.05 increase in left ventricular ppANP mRNA levels. PpANP mRNA levels in the septal wall and right ventricular Ž chamber also remained elevated at 4 weeks 2.4-, 1.7-fold;
. P -0.05; Fig. 2F , with less evidence of a gradient across the septum.
Cardiac a-actin mRNA
Sham leÕels
Cardiac ACT mRNA was homogeneously expressed throughout the chambers of the adult heart, with up to Ž 2-fold higher levels in atria, compared to ventricles Table  . 3, Fig. 3A . 
LVMI leÕels
At 24 h, left and right atrial cACT mRNA levels were not significantly different from sham, while left ventricular Ž levels were significantly reduced 57% decrease; P -0.05, . Table 3 , with cACT mRNA detected in the infundibulum, papillary muscle and apex of the heart, but not in the Ž . infarcted area Fig. 3E . At this time, right ventricular cACT mRNA levels were unchanged, although elevated levels were present in areas of the right ventricular free-wall Ž . Fig. 3E . By 1 week post-LVMI, cACT mRNA levels had Ž . increased 1.9-fold P -0.05 in both atria compared to 
Ž
. sham hearts Table 3 . Left ventricular cACT mRNA levels, however, were not altered, although increased expression in regions of the free-wall and apex were now Ž . apparent Fig. 3F . Septal and right ventricular cACT mRNA levels remained at sham levels at this time. Four weeks post-LVMI, atrial cACT mRNA levels remained Table 1 . % 95% CI , LVMI levels as a % of sham-operated rats with 95% Ž . ) confidence interval ANOVA . P -0.05, significantly different to sham-operated rats at respective time points. 'Limit of detection' was defined as meanq2 s.d. of 'non-specific' hybridization levels; for cACT and sACT these were 30 and 27 dpmrcm 2 , respectively. Values less than this were defined Ž . as undetectable UD . elevated, while ventricular levels were not statistically different from sham, except for reduced expression in the Ž . thin, dilated free-wall of the left ventricle Fig. 3G . 
Skeletal a-actin mRNA
Sham leÕels
Skeletal ACT mRNA could not be detected in the heart Ž at any time point following sham-operation Table 3, Fig. . 3B , reflecting the quiescence of this fetal a-actin transcript.
LVMI leÕels
At 24 h, sACT mRNA was detected in both atria and ventricles, in particular in the right ventricular free-wall and epicardium and at the apex of the heart, where it was Ž . expressed in a punctate pattern Table 3 , Fig. 3H . At 1 Ž and 4 weeks, sACT mRNA levels remained elevated Ta-. ble 3 , particularly at 1 week in the left atria, in the infundibular epicardium and septal endocardium of the left ventricular chamber and in the right ventricular free-wall Ž . and apex Fig. 3I . At 4 weeks, sACT mRNA was evident in both atria and in a punctate distribution throughout the Ž . right ventricular free-wall and apical regions Fig. 3J . Table 1 . % 95% CI , LVMI levels as a % of sham-operated rats with 95% Ž . ) confidence interval ANOVA . P -0.05, significantly different to sham-operated rats at respective time points. 'Limit of detection' was defined as 2 Ž . meanq2 s.d. of 'non-specific' hybridization levels; for MLC-2v mRNA this was 152 dpmrcm . Values less than this were defined as undetectable UD .
( )Interestingly, unlike other transcripts, sACT mRNA expression was evident in the infarcted area of the left ventricular free-wall at 1 and 4 weeks.
Myosin light chain-2 mRNA
Sham leÕels
Myosin light chain-2v mRNA was expressed at high levels throughout ventricular chambers of the heart, with a graded increase peaking at the apex. Atrial levels were Ž low, approximately twice the limit of detection Table 4 , .  Fig. 4A,C . 
LVMI leÕels
Myosin LC-2v mRNA levels in atria changed little Ž . during the 4-week study period Table 4 . At 24 h, MLC-2v mRNA expression was not detectable in the ischemic region of the left ventricular free-wall, and was largely restricted to the infundibulum, where it was present in Ž . highest density at the endocardial surface Fig. 4B . As a consequence, left ventricular MLC-2v mRNA was reduced Ž . Ž . by 56% P -0.05 , as were septal levels 28%; P -0.05 , due to the extension of the ischemic region into the septal myocardium. In contrast, right ventricular MLC-2v mRNA levels were unaltered at this time. Except for the left ventricular free-wall infarct area at 1 and 4 weeks, MLC-2v mRNA levels were homogeneous and relatively high throughout ventricular chambers, although at levels not Ž . significantly different from those of sham Table 4 . There was however, as with other mRNAs, increased MLC-2v mRNA levels evident at 1 week in the infundibulum, epicardium, septal endocardium and papillary muscle of Ž . . the left ventricular chamber and in the apex Fig. 4D . At 4 weeks, MLC-2v mRNA levels were maximal in the left ventricular free-wall endocardium and at the apex of the Ž . heart Fig. 4F . 
b-Myosin heaÕy chain mRNA
Sham leÕels
b-Myosin HC mRNA in sham-operated hearts was detectable at a diffuse, homogeneous level in ventricular Ž . chambers, but not in atria Table 5 , Fig. 5A,C . 
LVMI leÕels
Atrial levels of b-MHC mRNA remained undetectable until 4 weeks, when b-MHC was present at levels near the Ž detection limit adopted for this study see Section 2.8;
. Table 5 . At 24 h, left and right ventricular b-MHC mRNA levels were unaltered compared to sham levels, although 2 out of 5 hearts displayed homogeneously increased mRNA throughout the right ventricular free-wall Ž . and apex Fig. 5B . The endocardial surface of the interventricular septum also displayed increased b-MHC mRNA levels at this time. At 1 and 4 weeks, b-MHC mRNA levels in the left ventricle were significantly in-Ž duced above those of sham 3.0-4.0-fold; P -0.05; Table  . 5 , particularly in the epicardium bordering the infarct area, infundibulum and papillary muscle at 1 week, and in Ž the endocardium and infundibulum at 4 weeks Fig. 5D , . F . Septal b-MHC mRNA levels were similarly increased Ž . at 1-1.8-fold; P -0.05 and 4 weeks, particularly in the apex and at 1 week at the septal surface of the left ventricular endocardium. Right ventricular b-MHC mRNA levels at 1 week were not significantly different from Ž sham, whilst levels were induced at 4 weeks 3.7-fold;
. P -0.05 , with 3 out of 5 infarcted hearts displaying Ž . increased expression in the outflow tract Fig. 5F . 
Discussion
Results of the present study extend our knowledge of the altered expression of myocardial protein mRNA following experimental infarction and during the development of cardiac hypertrophy and chronic heart failure. Using in situ hybridization histochemistry we have detailed the spatiotemporal distribution of constitutive and inducible mRNA transcripts for the major components of Ž . the contractile apparatus actin, myosin and for natriuretic peptide in atrial and ventricular regions of the post-LVMI rat heart. In particular, we demonstrated a ventricular re-expression of mRNA encoding the natriuretic peptide precursor ppANP, an induction of mRNA encoding the fetal contractile proteins sACT throughout the heart and b-MHC in the ventricles, and the up-regulation of cACT mRNA in the atria following LVMI.
Infarct size, myocyte morphometry
Ž Infarct size 44.5 " 2.7% of combined left ventricular . epi-and endocardial surface area was examined in a representative group of rats 1 week post-LVMI, and found to be typical of 'large' infarcts, as classified by Pfeffer and w x coworkers 18 . Fiber width of left ventricular-papillary, mid-septal and mid-right ventricular myocytes was significantly increased as a result of LVMI from 1 week, reflecting the development of myocyte hypertrophy. These results are in accord with fiber width changes described in enzymatically dissociated myocytes following experimenw x tal infarction of up to 1 month duration 30 . In the current study, morphological changes were evident from 1 week in Ž . left papillary, mid-septal and right ventricular myocytes, and increased at 4 weeks in both ventricles, coinciding with the temporal mRNA changes described herein for b-MHC, but proceeding those described for ppANP and sACT.
Cardiac mRNA leÕels
The interpretation of cardiac mRNA levels post-LVMI is complicated by the fact that several processes are progressing simultaneously, namely a loss of mRNA expression in areas of the left ventricular free-wall, an associated inflammatory response, and the progressive development of acute, followed by chronic, cardiac decompensation and hypertrophy. Results obtained in the current study suggest that in non-compromised ventricular areas mRNA expression is induced as early as 24 h. By contrast, a transitory loss of all mRNAs studied was detected in the left ventric-Ž ular free-wall and septal apex at 24 h for example, Fig. . 4B , presumably because of an acute down-regulation of w x myocardial metabolism 31 . By 1 week post-LVMI, mRNA expression was restored in peri-infarct areas, possiw x bly due to angiogenesis and collateralized perfusion 32 . Subsequently this area forms the infarct scar, through w x apoptosis, necrosis 33 and lateral slippage of cardiomyw x ocytes 34 , leading to progressive left ventricular dilatation, this process of infarct expansion and chamber dilata-Ž tion making interpretation of mRNA changes measured as . hybridization signal density per unit area , somewhat difficult. In contrast, the absence of scar formation in septal and right ventricular chambers during the development of progressive cardiac hypertrophy allows a clearer discrimination of mRNA changes.
Atrial natriuretic peptide mRNA
Changes in ppANP mRNA are of particular interest. Ž Post-LVMI, atrial ppANP mRNA levels measured as 2 . dpmrcm were essentially unaltered. However, as a consequence of the progressive development of atrial hyper-Ž . trophy, ppANP mRNA hybridization signal dpm in-( )creased over the study period. A significant decrease in left atrial ppANP mRNA below sham levels was observed at 24 h post-LVMI, although this normalized by 1 week. While the exact reasons for this result are unclear, it is possible that acute ventricular dysfunction and the resultant acute left atrial distension immediately upon ligation of the LAD may cause the transitory loss of atrial myocyte transcription in a manner similar to that observed at 24 h in the ischemic areas of the left ventricular and septal w x myocardium 31 . This may also explain similar reductions evident in left atrial MLC-2 mRNA levels, and to a lesser extent cACT mRNA levels at this time.
In the ventricles, except for the ischemic areas of the free-wall and apex of the left ventricle at 24 h, ppANP mRNA was rapidly induced, a striking finding considering the normal quiescence of the ppANP gene in the adult ventricle. In the left ventricular chamber, ppANP mRNA levels reached their highest values by 1 week post-LVMI, presumably reflecting the activation of new protein synthew x sis mechanisms within the myocardium 35 , and remained elevated at 4 weeks. Septal and right ventricular ppANP mRNA levels were also rapidly induced and remained elevated throughout the study period. As in the atria, significant ventricular hypertrophy also occurred over the Ž . 4-week study period 1.8-fold heartrbody weight increase , largely due to septal and right ventricular hypertrophy. This was associated with a progressive 2.9-fold increase in lungrbody weight ratio indicative of the development of chronic heart failure. Our data is therefore consistent with previous reports of elevated ventricular ppANP mRNA w x during the chronic phase of experimental infarction 35 . By contrast to the rapid induction reported here, an earlier report using this experimental model described a delayed appearance of immunofluorescent ANP peptide in the right w x ventricle 4-6 days, post-LVMI 36 . This suggests that either there is a marked post-transcriptional delay in the conversion of ppANP mRNA to ANP peptide, or alternatively, a difference in the sensitivity of the two techniques.
The spatial distribution of ppANP mRNA induction in the present study is also consistent with reports describing a gradient of ANP immunoreactivity extending from the endo-to epicardial surface of acute and chronic volumeoverload ventricles, which in turn correlates with the distriw x bution of transmural wall stress 37 . Thus, ppANP mRNA hybridization was consistently present at peak intensity at the apex of the heart, an area known to be subject to maximal increases in mid-wall circumferential stress, w x post-LVMI 38 . However, an intense hybridization signal was also present, post-LVMI, in the left ventricular epicardium bordering the scar and in the infundibulum, areas that are less subject to altered mid-wall stresses. This suggests that wall stress per se may not be entirely responsible for ppANP mRNA expression post-LVMI and this, coupled with the observation that primary cultures of atrial and ventricular myocytes exposed to neuroendocrine stimuli have previously shown rapid induction of ppANP w x mRNA 35 , suggests that local auto-andror paracrine and circulating endocrine stimuli may play a role in inducing w x this quiescent gene 39 . Indeed, ANP peptide itself has demonstrable anti-trophic effects on vascular endothelial w x w x 40 and smooth muscle cells 35 , and the ability to inhibit w x DNA synthesis in cardiac fibroblasts 41 , suggesting the potential for local anti-hypertrophic actions, post-LVMI.
Cardiac and skeletal a-actin mRNA
A striking feature of iso-actin mRNA expression post-LVMI was the up-regulation of adult cACT mRNA in both Ž . atria 2-fold as well as in localized ventricular regions, and the induction of fetal sACT mRNA throughout the Ž . heart Table 3 . Regulation of atrial cACT mRNA in experimental cardiac overload has not been previously described, although in vivo studies in rat models of abdomw x w x w x inal 2 and early thoracic aortic stenosis 4 and LVMI 8 , and in vitro studies following a -adrenergic receptor stim-1 w x ulation of cultured neonatal rat ventricular myocytes 1 , suggest that the cACT gene is not a target for mechanisms that trigger ventricular hypertrophy. These studies however, employed Northern blotting, primer extension or endonuclease VII assays to measure cACT mRNA levels in ventricular muscle, whereas the use of in situ hybridization in the current study allowed identification of localized up-regulation of mRNA levels in the infundibulum, in areas bordering the infarct scar and at the apex of the heart post-LVMI. While this localized cACT mRNA increase was insufficient to increase left ventricular levels, due to the loss of expression in the infarct scar, or significantly elevate septal or right ventricular cACT mRNA, levels were increased in similar areas to those containing increased ppANP and sACT mRNA. This suggests a lesser, but common response to damage andror functional, metabolic or hormonal change.
Skeletal ACT mRNA, which was undetectable in sham hearts throughout the study period, in line with previous w x ontogenic studies 42 , was clearly evident post-LVMI early in the right atrium, ventricle and septum and later in the left atrium and ventricle. The spatiotemporal change in induced ventricular sACT mRNA was similar to that for ppANP mRNA, with peak hybridization signal consistently detected at the apex of the heart and in the left ventricular w x epicardium at 1 week, consistent with both mechanical 37 and local andror circulating neuroendocrine stimuli initiatw x ing these effects 1,43,44 . To our knowledge, this study is the first to describe early right ventricular and septal induction and differential atrial induction of sACT mRNA, post-LVMI, although the latter phenomenon has been reported for the left atria in the early stages of experimental w x thoracic aortic stenosis 3 . The functional significance of sACT mRNA expression is uncertain, however it has been suggested that over-expression can be correlated to inw x creased myocardial contractility in BALBrc mice 10 and may confer improved contractile efficiency in the setting of cardiac hypertrophy and failure.
( )The relevance of these changes to humans, where sACT represents 60% of the adult ventricular isoactin mRNA w x Ž . 45 , in contrast to that of the rat -20% , remains uncertain. Iso-actin switching in human cardiac hypertrophy has thus far only been studied in cardiac transplantation patients where no change in ventricular a-iso-actin w x composition was noted 46 .
Myosin light chain-2 mRNA
Following LVMI, MLC-2v mRNA levels were transiently decreased in left atria, ventricle and septum and thereafter normalized to sham levels. MLC-2v mRNA levels were unaltered in all other chambers. The apparent lack of ventricular MLC-2v mRNA modulation post-LVMI contrasts with the increases in ppANP and sACT mRNAs, and again may reflect different regulatory mechanisms to those required for the induction of fetal gene phenotypes. Indeed, the MLC-2v promoter is known to be regulated by a complex E-box independent mechanism, unlike that for w x the a-iso-actin and b-MHC genes 47 . However, like cACT mRNA, MLC-2v mRNA levels were elevated in similar discrete regions post-LVMI, without increasing overall chamber values, suggesting a lesser response to common stimuli. This localized up-regulation is consistent with results in a murine model harboring a MLC-2-luciferase transgene subject to 4 days of aortic banding, which displayed a 3-5-fold increase in left ventricular w x MLC-2v mRNA 48 , and with results following abdomiw 3 x nal aortic stenosis in the rat, where H leucine incorporation into the phosphorylated form of MLC-2v protein w x significantly increased in the hypertrophic heart 49 . Furthermore, in human cardiac hypertrophy and in renal-hypertensive baboons, MLC-2v protein levels have been shown to increase in hypertrophied atria and correlate with w x the degree of overload 50,51 . Again, as with ppANP and sACT mRNA, results from in vitro studies indicate that w x w x both mechanical 52 and neuroendocrine 49 stimuli upregulate MLC-2v mRNA expression, highlighting the potential for common stimuli to initiate gene expression post-LVMI.
b-Myosin heaÕy chain mRNA
b-Myosin HC mRNA was undetectable in atria until 4 weeks post-LVMI, in line with reports describing a delayed appearance in the left atria 30 days after thoracic w x aortic stenosis 3 . In the ventricles, however, b-MHC mRNA was induced within 1 week, initially in the septum and left ventricle and subsequently in the right ventricle.
The spatial distribution of b-MHC mRNA was similar to that described for sACT mRNA, although the punctate hybridization signal of sACT mRNA contrasted with the relatively homogeneous signal of b-MHC mRNA. Moreover, an endo-to epicardial gradient of b-MHC mRNA in the ventricular wall was apparent, consistent with previous reports in the rat following early thoracic-and chronic w x abdominal aortic stenosis 3,53 and closely correlated with w x reported alterations in wall stresses post-LVMI 37,38 . However, we were unable to consistently observe the high b-MHC mRNA levels surrounding intramyocardial vessels w x described by Schiaffino and coworkers 3 , presumably because, unlike their stenosis model, passive mechanical stretch due to elevated coronary perfusion pressure is not a major factor following LVMI. In addition to wall stress, neuroendocrine stimuli are also known to be candidates for w x inducing expression of the b-MHC gene in vitro 54-56 . Functionally, expression of b-MHC mRNA and recombination of its encoded protein into the sarcomere may depress contractility, as observed both in vitro and in vivo, w x due to a slower rate of ATP cycling by b-MHC 9 resulting in a slower, more economic contraction. Human ventricles are normally composed of 90% b-MHC isomyosin and switching has been reported in patients with cardiac hypertrophy due to chronic mitral valve stenosis, Ž where ventricular a-MHC protein normally expressed at . 5-15% of total heavy myosin levels disappeared in rew x sponse to long-standing pressure-overload 57 . Similarly, in human atria which predominantly express a-MHC protein, exposure to chronic pressure-overload induced an almost complete reversion to b-MHC, which correlated w x with the degree of atrial pressure-overload 58 . It is of interest that although major differences exist between rats and humans in the relative proportions of sACT and b-MHC mRNA in ventricular muscle, parallel increases in the levels of these transcripts occur in both species during cardiac overload.
The current study did not address the regulation of the translation of proteins encoded for by the induced mRNAs, since previous evidence indicates that molecular regulation w x of these genes is largely pre-translational 47 , with parallel accumulation of corresponding proteins widely reported following pressure-and volume-overload. Increased levels of cardiac protein arising from the translation of induced mRNA post-LVMI may confer adaptability to the contractile demands of the hemodynamically overloaded myocardium through incorporation into recombinant sarcom-Ž . eres sACT, b-MHC , and may have the potential for local Ž . w x anti-hypertrophic actions ppANP 36,40,41 . Interestingly, although variations existed between individual mRNA levels, the spatial distribution was similar for all induced genes post-LVMI, particularly in the ventricle Ž . apex, left ventricular endocardial surface, infundibulum , suggesting that similar cis-andror trans-activating factors may direct their myocardial expression. Indeed, altered diastolic wall stress due to redistribution of cardiac loading post-LVMI appears a primary candidate for initiating fetal w x gene induction 37 , although increases in local paraandror autocrine stimuli such as catecholamines, angiotensin-II and endothelin may also account for altered Žw x mRNA levels following experimental infarction 16,47 ; w x. for review see 59 . 
